Mdma molecule:

Image from PubChem

Mdma Clinical Trials


Phase II Clinical Trial Testing the Safety and Efficacy of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Subjects With Chronic Posttraumatic Stress Disorder


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00090064

Organisation Name: Multidisciplinary Association for Psychedelic Studies

Overal Status: Completed

Start Date: March 2004

Last Update: July 6, 2022

Lead Sponsor: Multidisciplinary Association for Psychedelic Studies

Brief Summary: This randomized, double-blind placebo-controlled study assessed the safety and effectiveness of MDMA-assisted therapy among people with chronic, treatment-resistant PTSD, including veterans. The study enrolled 23 participants. Participants were assigned to receive either therapy with a single divided dose of MDMA or lactose placebo during two blinded experimental sessions spaced three to five weeks apart during Stage 1 of the study. During these experimental sessions, participants received an initial dose of 125 mg of MDMA followed by a supplemental dose of 62.5 mg of MDMA, or they received initial and supplemental doses of inactive placebo.

Conditions:
  • Posttraumatic Stress Disorder


Total execution time in seconds: 0.24987506866455